Worldwide Market Reports recently released “Global Neuromodulation Market Research Report 2017” that centers around the latest developing trends and technologies in the Neuromodulation Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022.
During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives and other key people to have ready-to-access and self-analyzed study.
Get Report Sample @ https://www.worldwidemarketreports.com/sample/56732
The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.
Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.
North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia-Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.
Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.
Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.
Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021. The report also entails major drivers and challenges of neuromodulation market.
Neuromodulation Market: Segmentation
Neuromodulation market is classified on the basis of technology, application, company and geography.
Based on Technology, Neuromodulation market can be segmented as follows:
• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Other Technologies
Based on Application, Neuromodulation market can be segmented as follows:
• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Other Applications
Based on Geography, Neuromodulation market can be segmented as follows:
• North America
• Asia Pacific
• Latin America
• Rest of the World (ROW)
Based on Company, Neuromodulation market can be segmented as follows:
• Boston Scientific
• St Jude Medical
• Liva Nova(Cyberonics)
Get Report Discount @ https://www.worldwidemarketreports.com/discount/56732
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Worldwide Market Reports
Tel: +1 415 871 0703
Email: [email protected]
Visit our new Website:https://www.coherentwire.com